• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Machine Learning Model Improves Initial Gonadotropin Dose Accuracy in Antagonist Protocols

by
November 18, 2026
in Health
Reading Time: 3 mins read
0
Machine Learning Model Improves Initial Gonadotropin Dose Accuracy in Antagonist Protocols

Machine Learning Model Improves Initial Gonadotropin Dose Accuracy in Antagonist Protocols

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

An ensemble machine learning model demonstrated greater predictive accuracy than conventional clinical formulas for determining initial gonadotropin doses in ovarian stimulation antagonist protocols, according to a retrospective study of 1,970 women treated at Peking University People’s Hospital. The Light Gradient Boosting Machine model achieved a test set mean absolute error of 53.25 international units and a coefficient of determination of 0.527, substantially outperforming the baseline formula benchmark.

Determining the starting dose of gonadotropin presents critical clinical challenges within in vitro fertilization treatments utilizing gonadotropin-releasing hormone antagonist protocols. Although antagonist protocols have gained widespread adoption due to their shorter overall treatment duration, reduced risk of ovarian hyperstimulation syndrome, and greater convenience for patients compared with long agonist regimens, initial dose selection remains particularly difficult. The shorter suppression phase and accelerated follicular recruitment characteristic of antagonist cycles require precise dosage calibration from the start of ovarian stimulation.

Inappropriate starting dosages in these assisted reproduction cycles carry substantial clinical risks for patients. Administering excessive amounts of gonadotropins can trigger severe complications such as ovarian hyperstimulation syndrome, whereas insufficient dosing frequently results in a poor ovarian response or premature cancellation of the treatment cycle. Despite these significant risks, standard clinical practice has continued to depend on simple linear regression nomograms and traditional formula-based calculations, which exhibit limited predictive performance, particularly in complex clinical presentations that subsequently necessitate mid-treatment dosage adjustments.

To address these dosing limitations, researchers analyzed clinical records collected between October 2016 and December 2021 from 1,970 female patients undergoing antagonist protocols at Peking University People’s Hospital. The research team evaluated multiple computational algorithms, including standard linear regression, random forest, and support vector regression frameworks. Following preliminary assessments of model performance, the investigators selected two advanced computational architectures—the Light Gradient Boosting Machine and a Multi-Layer Perceptron neural network—specifically designed to capture high-dimensional medical features and nonlinear physiological relationships.

Across the test dataset, the Light Gradient Boosting Machine, an ensemble learning method operating on gradient-boosted decision trees, consistently surpassed standard predictive benchmarks. While the traditional baseline formula produced a test set mean absolute error of 61.03 international units and an R² of 0.298, the gradient boosting model reduced the error to 53.25 international units while increasing the explained variance to 0.527. Concurrently, the Multi-Layer Perceptron neural network attained the lowest overall mean relative error at 0.212, improving upon the baseline formula relative error of 0.271.

The gradient boosting model proved particularly advantageous in challenging patient scenarios where clinical teams originally had to modify medication doses during stimulation. In these complex cases requiring dose modifications, the Light Gradient Boosting Machine achieved a mean absolute error of 67.53 international units. This algorithmic performance was substantially lower than the observed clinical adjustment error of 87.07 international units, demonstrating that the machine learning algorithm delivered more precise dosing recommendations than retrospective clinician estimates under difficult therapeutic conditions.

The investigators concluded that integrating machine learning algorithms, notably gradient boosting architectures, into clinical decision support systems could substantially improve initial gonadotropin dose optimization in antagonist regimens. Such computational tools could potentially enhance assisted reproductive outcomes, reduce patient complication rates, and lower overall fertility treatment costs. The authors noted that translating these models into everyday reproductive medicine will require prospective multicenter validation studies, the creation of accessible clinical user interfaces, and the investigation of deeper neural network architectures to further advance predictive precision.

Subject of Research: Machine learning prediction of initial gonadotropin dosage in IVF antagonist protocols

Article Title: Machine learning-based prediction of initial gonadotropin dosage in antagonist protocols

Article References: Wu, D., Yu, Y.-Q., Zhang, Z., Shen, H., Wang, Y.-B., Han, H.-J., Zhang, M., & Gao, F.-M. (2026). Machine learning-based prediction of initial gonadotropin dosage in antagonist protocols. Journal of Ovarian Research. https://doi.org/10.1186/s13048-026-02348-8

Image Credits: AI Generated

DOI: 10.1186/s13048-026-02348-8

Keywords: machine learning, gonadotropin dosing, antagonist protocol, in vitro fertilization, ovarian hyperstimulation syndrome, Light Gradient Boosting Machine, Multi-Layer Perceptron, follicular recruitment, Peking University People's Hospital, retrospective cohort study, mean absolute error, dose modification, decision support systems, poor ovarian response, cycle cancellation, clinical dose optimization

News Source: Teresa Odom. (November 18, 2026). Machine Learning Model Improves Initial Gonadotropin Dose Accuracy in Antagonist Protocols. Scienmag.

Tags: antagonist protocolclinical dose optimizationcycle cancellationdecision-support systems**dose modificationfollicular recruitmentgonadotropin dosingin vitro fertilizationlight gradient boosting machineMachine Learningmean absolute errorMulti-Layer Perceptronovarian hyperstimulation syndromePeking University People's Hospitalpoor ovarian responseretrospective cohort study
Share12Tweet7Share2ShareShareShare1

Related Posts

Three Pre-Cooling Markers Predict Brain Injury Risk in Cooled Newborns

Three Pre-Cooling Markers Predict Brain Injury Risk in Cooled Newborns

November 18, 2026
Postpartum Body Dissatisfaction May Worsen Depressive Symptoms for Some Mothers With Obesity

Postpartum Body Dissatisfaction May Worsen Depressive Symptoms for Some Mothers With Obesity

November 18, 2026

Dominant Cystic Lesions Impair Visual Search for Subtle Dental Pathologies

November 18, 2026

Meta-Analysis Links Elevated Salivary Endothelin-1 Levels to Oral Squamous Cell Carcinoma

November 18, 2026

POPULAR NEWS

  • Area Disadvantage Outweighs Personal Socioeconomic Status in Chronic Hepatitis B Liver Fibrosis

    Area Disadvantage Outweighs Personal Socioeconomic Status in Chronic Hepatitis B Liver Fibrosis

    29 shares
    Share 12 Tweet 7
  • Seven-Country Study Finds EQ-5D Captures Core Aspects of Poor Health Across Cultures

    29 shares
    Share 12 Tweet 7
  • Alnus trabeculosa Tree Compounds Protect Mitochondria in Parkinson’s Disease Cellular Models

    29 shares
    Share 12 Tweet 7
  • Dordaviprone Review Details Multi-Pathway Activity Against Aggressive Midline Gliomas

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Three Pre-Cooling Markers Predict Brain Injury Risk in Cooled Newborns

Nanoparticle Formulation Reduces Gas-Induced Package Swelling in Fermented Sauerkraut

Structured Sparse Attention Cuts Long-Context Diffusion Model Latency in Half

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.